← Back to headlines
Marvel Biosciences Adjusts Debenture Offering Terms
Marvel Biosciences has announced a reduction in the conversion price for its proposed debenture offering, impacting its financial structure.
13 Apr, 21:38 — 13 Apr, 21:38
Sources
Showing 1 of 1 sources
